Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Steve Harmon who wrote (1378)	8/27/1998 7:58:00 PM
From: Jace	Read Replies (2) \| Respond to of 2742

I don't get it, how are they going to push up the price? All Cistron has is a POTENTIAL adjuvant. They have only results in rats that we know of. There are a lot of other adjuvants out there. Why do you expect so much from IL1? I'm glad to even be breaking even here, the competition in this market is fierce! I was more hopeful (and originally invested bcz of)the other uses for IL1 like the periodontal application. I never expected them to recover from that one. A cytokine as an adjuvant without side effects is incredible! This whole thing will be dumped in a minute if side effects show up later. Also, they have so little money, really. How much research do you think a couple of million dollars can do. You couldn't do a sizable human clinical. Any large animal expt. would be a couple of hundred thousand... I'm impressed with them if they actually pull this deal off --- you know, it isn't for sure yet... only when it is assured will the stock rise... and then, thank your lucky stars you made money off a PENNY STOCK!)